The Motley Fool

HubSpot Earnings: No AI Boost in 2025

Here's our initial take on HubSpot's (NYSE: HUBS) fourth-quarter financial repor...

Why Arista Networks Stock Sank Today

Arista Networks (NYSE: ANET) stock lost ground in Wednesday's trading. The compa...

The Trade Desk Revenue Falls Short

The Trade Desk exceeded earnings expectations, but revenue fell short of estimat...

Dutch Bros Q4 Revenue Jumps 35%

Dutch Bros reported strong earnings for Q4 2024, surpassing revenue and EPS esti...

MGM Resorts' Q4 EPS Outpaces Estimates

The gambling and resort giant delivered a strong quarterly earnings beat driven ...

Paycom Looks to Turn the Corner

Here's our initial take on Paycom Software's (NYSE: PAYC) fourth-quarter financi...

Equinix Misses EPS Mark, Revenue Rises

Equinix reported steady growth in Q4 2024, and management forecasted continued g...

Cognex Tops Expectations on Revenue, EPS

Cognex beat Wall Street's estimates in the fourth quarter, but faced some challe...

Meet the Monster Stock That Continues to Crush the Market

Every growth investor dreams of coming across the next Nvidia or Palantir stock....

S&P Global: Buy, Sell, or Hold?

The company has minted millionaires with decades of capital gains and dividend g...

HubSpot Surpasses Q4 Revenue Estimates

HubSpot reported strong quarterly earnings, outpacing both management's guidance...

Philip Morris International Shares Surge as Transformat...

While investors in the tobacco space have tended to be more focused on dividends...

Should You Forget AMD and Buy 2 Tech Stocks Instead?

Broadcom and TSMC might be more balanced chipmaking investments.

Reddit’s EPS Shines, Beats Projections

Reddit reported solid fourth-quarter results with notable revenue growth, but fa...

Tesla Stock Is Down 13% in 2025: Is It a Long-Term Buy?

In the past few months, shares of Tesla (NASDAQ: TSLA) have rapidly accelerated,...

Why CRISPR Therapeutics Stock Was a Massive Winner on W...

On Hump Day, investors piled into CRISPR Therapeutics (NASDAQ: CRSP) stock, send...

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.